Title |
Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis
|
---|---|
Published in |
International Journal of Chronic Obstructive Pulmonary Disease, September 2013
|
DOI | 10.2147/copd.s48967 |
Pubmed ID | |
Authors |
Andreas Karabis, Leandro Lindner, Michelle Mocarski, Eline Huisman, Andrew Greening |
Abstract |
Aclidinium bromide is a new long-acting muscarinic antagonist (LAMA) indicated for maintenance bronchodilator treatment of chronic obstructive pulmonary disease (COPD). The efficacy of aclidinium was compared with tiotropium and glycopyrronium, using a network meta-analysis (NMA) of randomized controlled trials (RCTs) in moderate-to-severe COPD patients. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Scientists | 1 | 33% |
Members of the public | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 1% |
Netherlands | 1 | 1% |
Canada | 1 | 1% |
Unknown | 84 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 17 | 20% |
Student > Postgraduate | 16 | 18% |
Researcher | 15 | 17% |
Other | 10 | 11% |
Student > Ph. D. Student | 6 | 7% |
Other | 16 | 18% |
Unknown | 7 | 8% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 54 | 62% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 7% |
Agricultural and Biological Sciences | 4 | 5% |
Chemistry | 2 | 2% |
Mathematics | 2 | 2% |
Other | 7 | 8% |
Unknown | 12 | 14% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 October 2019.
All research outputs
#4,261,686
of 25,373,627 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#509
of 2,577 outputs
Outputs of similar age
#35,347
of 212,473 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#5
of 16 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,577 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,473 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.